EGFR/KRAS mutations in African Americans (AA) versus Caucasians (CA) in patients with NSCLC: A comparative analysis of the South Carolina experience.

Abstract

e18018 Background: AAs with NSCLC has inferior survival compared to CAs (Abidoye, Nature 2007). We sought to discern whether differences in incidence of EGFR or KRAS mutations between races could partly explain these differences. METHODS Pts with NSCLC who were seen at the Hollings Cancer Center (HCC) and underwent EGFR and KRAS mutation testing in 2010… (More)

Topics

  • Presentations referencing similar topics